Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Definite Identification and Sequencing of SARS Virus

By HospiMedica staff writers
Posted on 21 Apr 2003
A network of 13 laboratories from all over the world, formed by the World Health Organization (WHO, Geneva, Switzerland) to find the cause of acute severe respiratory syndrome (SARS), has announced the identification of the SARS pathogen as a member of the coronavirus family never before seen in humans.

The researchers have named the pathogen "SARS virus.” WHO and the network of laboratories have dedicated their detection and characterization of the virus to Dr. More...
Carlo Urbani, the WHO scientist who first alerted the world to SARS and who died from the disease in Bangkok (Thailand) in March 2003.

"Today, the collaboration continues as top laboratory researchers have come to WHO to design the next steps, a strategy for transforming these basic research discoveries into diagnostic tools that will help us to successfully control this disease,” said Dr. David Heymann, executive director of WHO communicable diseases programs.

Only days earlier, Canadian researchers had completed the sequencing of a coronavirus felt to be responsible for SARS and now confirmed, which is expected to lead to the development of definitive diagnostic tests for SARS and to an understanding of why the virus is so deadly. The sequence is posted on the website of the British Columbia Cancer Agency's Genome Sciences Center.

WHO scientists said this new member of the coronavirus family may have mutated from animals into humans. Concurrently, researchers at the US Centers for Disease Control (CDC, Atlanta, GA, USA) have finished their own sequencing of the virus. The new genetic information will be useful in developing a rapid diagnostic test and perhaps a vaccine. To date, there have been more than 3,000 cases of SARS, most occurring in China and Hong Kong.





Related Links:
WHO
BC Genome Sciences Center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.